Vivos Inc Summarizes Progress in its Animal Therapy Division
12/22/2025 12:56 PM • Vivos Inc.'s IsoPet division achieved 1,200% year-over-year growth in administered therapies from 2024 to 2025, with over 100 treatments safely performed across various animal species. The company expanded its certified clinic network to 17 locations by year-end 2025, including new certifications at Sun City Veterinary Surgery Center in Texas and University of Florida Small Animal Hospital. The division plans to implement profitability-focused initiatives in Q1 2026 while continuing clinic expansion, with multiple clinical publications anticipated to support veterinary adoption.
RDGL - The company demonstrated exceptional growth metrics (1,200% YoY increase), expanded its certified clinic network significantly, completed case study therapies, and secured strategic partnerships. Plans for profitability initiatives and anticipated clinical publications in 2026 further support positive momentum in the IsoPet division.
Investing.com • Sam Quirke